Douglas Lane & Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
HJGA
AAMU
Douglas Lane & Associates's QGEN Position: Q4 2017 in Review
Douglas Lane & Associates sold out of Qiagen (QGEN) in Q4 2017, closing a stake of 18,150 shares — an estimated $606K sold.
Douglas Lane & Associates first reported a position in QGEN in Q1 2017 and held it in 3 quarters. The position peaked at $38.7M in Q1 2017. 215 funds tracked by Wall St. Rank hold QGEN as of Q4 2017.
- Douglas Lane & Associates reported no remaining Qiagen position as of Q4 2017 after selling out during the quarter.
- Douglas Lane & Associates sold 18,150 Qiagen shares in Q4 2017, an estimated $606K.
- Douglas Lane & Associates first reported a position in Qiagen in Q1 2017 and held it in 3 quarters.
- Douglas Lane & Associates's Qiagen position peaked at $38.7M in Q1 2017.
- 215 funds tracked by Wall St. Rank held Qiagen as of Q4 2017.
Based on Douglas Lane & Associates's 13F filing for Q4 2017, filed 24 Jan 2018.